MK-677 and Thymosin Beta-4 Interaction

Synergistic
Mechanism-based 47% confidence

MK-677 and Thymosin Beta-4 have a synergistic interaction with 47% confidence. MK-677 and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Thymosin Beta-4

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation..

Half-life: Dose-dependent; relatively short (exact values not established) Typical dose: 2-6mg per injection (varies by protocol and severity) healing, immune, longevity
View full profile

Combined Organ Load

Brain
low
GI Tract
low
Pituitary
low
Blood Vessels
low

Frequently Asked Questions

Can I take MK-677 with Thymosin Beta-4?

Yes, MK-677 and Thymosin Beta-4 can generally be taken together. MK-677 and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is MK-677 and Thymosin Beta-4 safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between MK-677 and Thymosin Beta-4?

MK-677 and Thymosin Beta-4 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time MK-677 and Thymosin Beta-4?

MK-677 has a half-life of ~24 hours and Thymosin Beta-4 has a half-life of Dose-dependent; relatively short (exact values not established). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: MK-677 vs Thymosin Beta-4

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.